Table 5 Dimension 4: Crude and adjusted associations between patient characteristics and patients' evaluation of aspects of the organisation of care.
100% positive assessments 1 | 0–49% positive assessments 2 | ||||||||
|---|---|---|---|---|---|---|---|---|---|
Prev.(%) | PR | Adj. PR | 95% CI | Prev.(%) | PR | Adj. PR | 95% CI | ||
Gender | |||||||||
(N = 24154) | Female | 64.5 | 1 | 13 | 23.4 | 1 | 1 | ||
Male | 68.3 | 1.06 | 1.01 | 0.99 – 1.03 | 19.4 | 0.83 | 0.91 | 0.85 – 0.96 | |
Age (years) | |||||||||
(N = 24154) | 18–24 | 58.4 | 1 | 13 | 28.1 | 1 | 1 | ||
25–29 | 55.8 | 0.96 | 0.95 | 0.89 – 1.01 | 28.9 | 1.03 | 1.04 | 0.93 – 1.17 | |
30–34 | 58.6 | 1.00 | 1.00 | 0.95 – 1.07 | 27.0 | 1.00 | 0.94 | 0.84 – 1.05 | |
35–39 | 60.0 | 1.03 | 1.05 | 0.99 – 1.11 | 25.2 | 1.01 | 0.85 | 0.76 – 0.95 | |
40–44 | 62.0 | 1.06 | 1.11 | 1.04 – 1.18 | 24.3 | 1.00 | 0.78 | 0.69 – 0.89 | |
45–49 | 61.8 | 1.06 | 1.12 | 1.05 – 1.19 | 25.3 | 0.90 | 0.80 | 0.70 – 0.91 | |
50–54 | 65.5 | 1.12 | 1.20 | 1.13 – 1.28 | 22.2 | 0.88 | 0.68 | 0.60 – 0.78 | |
55–59 | 68.7 | 1.18 | 1.27 | 1.20 – 1.35 | 20.3 | 0.74 | 0.62 | 0.55 – 0.70 | |
60–64 | 71.6 | 1.23 | 1.33 | 1.25 – 1.41 | 18.0 | 0.67 | 0.55 | 0.48 – 0.64 | |
65–69 | 76.3 | 1.31 | 1.42 | 1.34 – 1.50 | 14.9 | 0.58 | 0.46 | 0.39 – 0.53 | |
70–74 | 77.7 | 1.33 | 1.44 | 1.36 – 1.53 | 14.9 | 0.53 | 0.46 | 0.39 – 0.55 | |
75–79 | 76.1 | 1.30 | 1.43 | 1.34 – 1.52 | 14.5 | 0.51 | 0.44 | 0.37 – 0.52 | |
80+ | 76.5 | 1.31 | 1.44 | 1.36 – 1.54 | 16.3 | 0.57 | 0.48 | 0.41 – 0.57 | |
Further education (years) | |||||||||
(N = 23058) | None | 68.5 | 1 | 1 | 20.4 | 1 | 1 | ||
Less than 2 | 65.1 | 0.96 | 1.00 | 0.96 – 1.03 | 22.2 | 1.09 | 1.00 | 0.90 – 1.11 | |
2–4 | 64.6 | 0.84 | 0.97 | 0.95 – 1.00 | 22.8 | 1.12 | 1.07 | 0.99 – 1.15 | |
5 or more | 64.8 | 0.79 | 0.98 | 0.95 – 1.01 | 23.0 | 1.13 | 1.11 | 1.00 – 1.22 | |
Undergoing education or other | 67.8 | 0.85 | 1.05 | 1.01 – 1.10 | 20.5 | 1.00 | 0.94 | 0.81 – 1.08 | |
Frequency of attendance (times per year) | |||||||||
(N = 24154) | 0–1 | 66.1 | 1 | 13 | 24.3 | 1 | 1 | ||
2–3 | 64.3 | 0.97 | 0.99 | 0.96 – 1.03 | 24.4 | 1.00 | 0.96 | 0.88 – 1.05 | |
4–5 | 65.1 | 0.98 | 1.01 | 0.97 – 1.04 | 22.5 | 0.93 | 0.87 | 0.80 – 0.95 | |
6–7 | 65.7 | 0.99 | 1.04 | 1.00 – 1.08 | 21.2 | 0.87 | 0.78 | 0.70 – 0.86 | |
8–9 | 68.0 | 1.03 | 1.08 | 1.03 – 1.13 | 19.4 | 0.80 | 0.70 | 0.62 – 0.80 | |
10+ | 68.2 | 1.03 | 1.12 | 1.08 – 1.17 | 18.7 | 0.77 | 0.63 | 0.57 – 0.69 | |
Duration of listing (years) | |||||||||
(N = 16168) | Less than 1 | 65.6 | 1 | 13 | 25.8 | 1 | 1 | ||
1–2 | 64.8 | 0.99 | 0.97 | 0.92 – 1.02 | 23.8 | 0.92 | 0.97 | 0.86 – 1.10 | |
3–7 | 65.6 | 1.00 | 0.96 | 0.92 – 1.01 | 21.9 | 0.85 | 0.92 | 0.82 – 1.04 | |
8–12 | 68.1 | 1.04 | 0.98 | 0.93 – 1.03 | 20.2 | 0.78 | 0.89 | 0.78 – 1.01 | |
13+ | 70.7 | 1.08 | 1.00 | 0.95 – 1.05 | 17.5 | 0.68 | 0.79 | 0.69 – 0.90 | |
Self-rated health | |||||||||
(N = 24154) | Excellent | 70.0 | 1 | 13 | 19.6 | 1 | 1 | ||
Very good | 67.1 | 0.96 | 0.92 | 0.89 – 0.95 | 21.2 | 1.08 | 1.18 | 1.07 – 1.30 | |
Good | 66.3 | 0.95 | 0.82 | 0.79 – 0.84 | 21.8 | 1.11 | 1.51 | 1.37 – 1.65 | |
Fair | 61.1 | 0.87 | 0.71 | 0.69 – 0.74 | 25.3 | 1.29 | 2.02 | 1.82 – 2.24 | |
Poor | 60.8 | 0.87 | 0.70 | 0.65 – 0.74 | 25.1 | 1.28 | 2.11 | 1.82 – 2.44 | |
Chronic condition | |||||||||
(N = 23810) | No | 64.9 | 1 | 13 | 23.4 | 1 | 1 | ||
Yes-KRTC | 71.2 | 1.10 | 1.03 | 1.01 – 1.06 | 17.9 | 0.77 | 0.88 | 0.81 – 0.96 | |
Yes-other or multiple | 63.8 | 0.98 | 1.00 | 0.98 – 1.03 | 22.7 | 0.97 | 0.93 | 0.88 – 1.00 | |
Chronic condition | |||||||||
(N = 16049) | None | 64.9 | 1 | 13 | 23.4 | 1 | 1 | ||
K – Cardiovascular | 66.3 | 1.14 | 1.05 | 1.01 – 1.09 | 19.8 | 0.68 | 0.85 | 0.76 – 0.96 | |
R – Respiratory | 73.8 | 1.02 | 1.02 | 0.97 – 1.07 | 16.0 | 0.95 | 0.96 | 0.85 – 1.09 | |
T – Endocrine | 66.2 | 1.09 | 1.03 | 0.99 – 1.08 | 22.1 | 0.81 | 0.92 | 0.80 – 1.07 | |
C – Cancer | 70.5 | 1.16 | 1.12 | 1.04 – 1.21 | 18.8 | 0.56 | 0.62 | 0.46 – 0.84 | |